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Background: This study investigates the effect of Xiao-Qing-Long-Tang (XQLT) on neurotrophin in an established
mouse model of Dermatophagoides pteronyssinus (Der p)-induced acute allergic asthma and in a LA4 cell line
model of lung adenoma. The effects of XQLT on the regulation of nerve growth factor (NGF) and brain-derived
neurotrophic factor (BDNF), airway hyper-responsiveness (AHR) and immunoglobulin E were measured.
Methods: LA4 cells were stimulated with 100 μg/ml Der p 24 h and the supernatant was collected for ELISA
analysis. Der p-stimulated LA4 cells with either XQLT pre-treatment or XQLT co-treatment were used to evaluate the
XQLT effect on neurotrophin.
Balb/c mice were sensitized on days 0 and 7 with a base-tail injection of 50 μg Dermatophagoides pteronyssinus
(Der p) that was emulsified in 50 μl incomplete Freund’s adjuvant (IFA). On day 14, mice received an intra-tracheal
challenge of 50 μl Der p (2 mg/ml). XQLT (1g/Kg) was administered orally to mice either on days 2, 4, 6, 8, 10 and
12 as a preventive strategy or on day 15 as a therapeutic strategy.
Results: XQLT inhibited expression of those NGF, BDNF and thymus-and activation-regulated cytokine (TARC) in
LA4 cells that were subjected to a Der p allergen. Both preventive and therapeutic treatments with XQLT in mice
reduced AHR. Preventive treatment with XQLT markedly decreased NGF in broncho-alveolar lavage fluids (BALF)
and BDNF in serum, whereas therapeutic treatment reduced only serum BDNF level. The reduced NGF levels
corresponded to a decrease in AHR by XQLT treatment. Reduced BALF NGF and TARC and serum BDNF levels may
have been responsible for decreased eosinophil infiltration into lung tissue. Immunohistochemistry showed that
p75NTR and TrkA levels were reduced in the lungs of mice under both XQLT treatment protocols, and this
reduction may have been correlated with the prevention of the asthmatic reaction by XQLT.
Conclusion: XQLT alleviated allergic inflammation including AHR, IgE elevation and eosinophil infiltration in Der p
stimulated mice by regulating neurotrophin and reducing TARC. These results revealed the potential
pharmacological targets on which the XQLT decotion exerts preventive and therapeutic effects in an allergic
asthma mouse model.
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The pathology of allergic asthma is characterized by clear
eosinophil infiltration in the airways and the elevation of
systemic IgE levels, mediated by type 2 T-helper (Th2)
cells and cytokines. Airway remodeling, observed in severe
form of allergic asthma, is a consequence of repetitive air-
way inflammation and Th2-type reaction. Although the
imbalance of Th1/Th2 immune response is well known
and has been used to elucidate the immune-pathogenesis
of allergy and other autoimmune diseases, this relevant
theory is incomprehensive and satisfactory clinical applica-
tions are lacking. Traditional Chinese Medicine (TCM)
decotion such as Xiao-Qing-Long-Tang (XQLT) is fre-
quently used in Asia for the clinical treatment of bronchial
asthma and allergic rhinitis [1,2], XQLT, in particular, has
been found to have beneficial effects in relieving Th2-
based reactions in the airways of animal models of allergic
asthma [3-6]. Despite its effects on immunological regula-
tion, the molecular mechanism and pharmacological ac-
tion of XQLT remain unclear. XQLT is highly popular in
TCM and complementary medicine, because it has no
major side effects. Therefore, the therapeutic targets and
ethno-pharmacological action of the decotion must be
thoroughly examined before it can be widely used for the
prevention and treatment of asthma.
Members of the neurotrophin family have been shown
not only to act as growth factors in the nervous system,
but also to act as pro-inflammatory factors in the immune
system. Airway hyper-responsiveness (AHR) can be medi-
ated through substance P, neurokinin A, and other mem-
bers of the neurotrophin family, suggesting that neural
hyper-innervation of the airways may be responsible for
AHR [7]. Nerve growth factor (NGF) which is a member
of the neurotrophin family is one product of activa-
ted Th2 cells [8,9]. Moreover, our recent research de-
monstrated that a major allergen of house dust mite,
Dermatophagoides pteronyssinus Group 2 (Der p 2) could
induce NGF production and reactive oxygen species in the
airway, as well as allergic inflammation after direct intra-
tracheal instillation into the lungs of mice [10].
NGF and the brain-derived neurotrophic factor (BDNF)
are survival and activation factors of eosinophil in patients
with allergic bronchial asthma [11]. NGF and BDNF are
expressed in multiple cells, including epithelial cells, active
immune cells, and neural cells. In allergic asthma, the tis-
sue that is primarily responsible for allergen presentation
is the bronchiolar epithelium. These epithelial cells
present allergens and induce allergy pathways that involve
multiple events, including dendritic cell activation and
chemokine secretion [12,13]. Moreover, NGF and BDNF
have been observed at elevated concentration in patients
with allergic diseases. Although BDNF has not yet been
implicated in early allergic reactions as NGF, its role in al-
lergic airway dysfunction has been found to be important[14]. BDNF is now known to be directly involved in airway
smooth muscle hyperplasia and hypertrophy by inter-
acting with tyrosine kinase B (TrkB), but not with p75
neurotrophin receptor (p75NTR), and through the secre-
tion of metalloproteinase-9 (MMP-9) [15,16]. BDNF is
also known responsible for neuronal plasticity in brain
and lung. Neuronal plasticity is also a key factor in airway
remodeling and airway hyper-responsiveness. p75NTR is
required for BDNF in regulating depression or anxiety in
brain function, but it is not a necessary factor in smooth
muscle hypertrophy which result in airway remodeling
[17,18]. p75NTR is a low-affinity receptor of all factors of
the neurotrophin family, and allergic inflammation and
eosinophil infiltration have been eliminated in p75NTR-
knockout mice [19,20]. p75NTR is known for inducing
NF-κB activation that has been demonstrated to be a
major transcriptional factor in the Th2-type immune re-
sponse [21,22]. NGF may also affect dendritic cells (DCs)
through p75NTR [23].
This paper presents our findings that XQLT inhibited
the production of the members of the neurotrophin fam-
ily in a mouse model of allergic asthma, alleviating AHR
and the allergic inflammation of the airway. LA4 is a
bronchial epithelial cell line of murine lung origin and
produces NGF in response to Der p allergen [10]. XQLT
has been found to inhibit NGF and BDNF and p75NTR
expression in LA4 cells. These results identified the po-
tential pharmacological targets of the XQLT decotion
that might exert its preventive and therapeutic effects in
a mouse model of allergic asthma.
Methods
TCM preparation: Xiao-Qing-Long-Tang (XQLT)
XQLT extract powder was kindly provided by KO-DA
Pharmaceutical Co. (Taoyuan, Taiwan, R.O.C.). All of the
eight herbs listed in description below were originally
grown in mainland China and collected by the KO-DA
Pharmaceutical Co. from professional herbal growers. The
voucher specimens have been deposited in the publicly
available herbarium of KO-DA Pharmaceutical Co. Those
eight herbs were authenticated by Professor Shih-Chang
Lee, China Medical University, Taiwan. The XQLT extract
was prepared as described in a previous study [24]. Briefly,
eight herbal ingredients were mixed by proportion which
is shown as number that is in the brackets behind each
scientific name of herbal. They were Pinellaiae tuber (6.0,
root of Pineliaternata breitenbach), Ephedrae herba (3.0,
stem of Ephedra sinica Stapf ), Schizandrae fructus (3.0, a
fruit of Schizandra chinensis Baill.), Cinnamonomi cortex
(3.0, cortex of Cinnamomum cassia Blume), Paeoniae
radix (3.0, root of Paeonia lactiora Pall.), Asariherba cum
radice (3.0, whole plant of Asiasarum heterotropoides F.
Maekawa var. mandshuricum F. Maekawa), Glycyrrhizae
radix (2.0, root of Glycyrrhiza uralensis Fisch. Et. DC), and
Chang et al. BMC Complementary and Alternative Medicine 2013, 13:220 Page 3 of 13
http://www.biomedcentral.com/1472-6882/13/220Zingiberis siccatum rhizoma (1.0, steamed root of Zingiber
officinale Roscoe). The mixture was extracted sequentially
with 17.5 L and 12.5 L boiling water each time for 1 h.
The extracted liquid was mixed and filtered. After filtra-
tion, the dregs of the decotion were removed. The filtered
liquid was lyophilized then crushed into a thin powder.
The yield of dried extract from starting crude material was
661.8 g (26.4%, w/w). The dried extract was subsequently
used for all experiments in this research. The batch num-
ber of XQLT extract is 98041021.
The XQLT mixture was suspended in distilled water to
a fixed concentration for being orally administered to the
mice through feeding needle and swallowing. The feeding
volume was adjusted within 0.2~0.3 ml to avoid mice of
pain. For in vitro use, the XQLT mixture was dissolved in
distilled water, after which the solution was centrifuged at
7500 rpm for 30 min. Following filtration, the aqueous ex-
tract was lyophilized and weighed. This XQLT extract was
re-dissolved in pyrogen-free isotonic saline (YF Chemical,
Taipei, Taiwan) and filtered through a 0.22-μm filter
(Microgen, Laguna Hills, CA, USA). A sample of the fil-
tered pyrogen-free solution was lyophilized and weighed.
The final concentration of the last filtered pyrogen-free so-
lution was estimated by the sample. The filtered pyrogen-
free solution was stored at -20°C until use.
Production of neurotrophin in cell lines following Der p
stimulation
LA4 (murine lung adenoma) cell line was purchased from
the Bioresource Collection and Research Center (BCRC,
Hsinchu, Taiwan; BCRC60239 derived from ATCC: CCL-
196). The LA4 cells were cultured in Ham’s F12 medium
(Gibco), which contained 2.5 mM L-glutamine, 15% fetal
bovine serum (FBS), and 0.1% gentamicin, in an incubator
at 37°C with 5% CO2. Group XC comprised LA4 cells that
were treated with XQLT alone for 24 h. Group XP com-
prised LA4 cells that were treated with XQLT for 1 h, then
the XQLT was washed out, subsequent to 24 h Der p
stimulation. Group XD comprised LA4 cells which were
simultaneously treated with XQLT and Der p for 24 h.
Group D comprised LA4 cells which were treated with
Der p alone for 24 h. Group N comprised entirely un-
treated LA4 cells. 1 mg/ml XQLT and 100 μg/ml Der p
concentrations set following a pre-titration trial (data not
shown) were administered to the cells in all groups. After
the treatment of all cell groups for 24 h, supernatants and
total cell protein were collected for analysis. All the proto-
cols were schematic in Figure 1A. LA4 cells were all
seeded at concentration of 1×106 cells/ ml.
Western blot analysis of NGF and p75NTR expression in
cell lines
Cells (1~2 × 106 cells/ml) were lysed using a Triton
X-100-based lysis buffer that contained 1% Triton X-100,150 mM NaCl, 10 mM Tris (pH 7.5), 5 mM EDTA, 5 mM
NaN3, 10 mM NaF, and 10 mM sodium pyrophosphate.
Cell extracts were separated using SDS-PAGE, then trans-
ferred to a PVDF membrane (Millipore Corporation,
Billerica, MA, USA). After blocking, the blots were devel-
oped using rabbit polyclonal anti-p75NTR antibody or
rabbit polyclonal anti-NGF antibody. The blots were then
hybridized using HRP-conjugated goat anti-rabbit IgG
(Calbiochem, San Diego, CA, USA) and developed with a
chemiluminescence kit (Western Lightning Chemilu-
minescence Reagent PLUS; PerkinElmer Life Sciences
Inc., Boston, MA, USA). The western band density that
corresponded to the p75NTR or NGF or pro-NGF or
β-actin was determined using an image analysis system.
The detected density was representation of expression
level of each protein. The density of p75NTR, NGF or
pro-NGF was calculated versus density of β-actin and
result was shown as proportion. The proportion was
plotted as bar graph with the value of group N set to
be 1. Single Antibody: anti-p75NTR {Abcam Inc.
ab8874}; anti-NGF {NGF (M-20), SANTA CRUZ BIO-
TECHNOLOGY, INC. sc-549}.
Acute asthma model set-up
Specific pathogen-free, 6~8 week-old female BALB/c mice
from the Laboratory Animal Center of National Cheng Kung
University were used in this study. The mice were housed in
microisolator cages (Laboratory Products, Maywood, NJ,
USA) and provided with sterile food and water ad libitum.
All care and treatment of the experimental animals followed
the guidelines set by the National Science Council of the Re-
public of China. The Institutional Animal Care and Use
Committee (IACUC) of the China Medical University (Per-
mit Number: 100-139-N) approved the protocol.
On days 0 and 7, groups of mice were subcutaneously
injected at the base of their tails with a 50 μl emulsion
that contained 50 μg of Der p in incomplete Freund’s ad-
juvant (IFA; Difco, Detroit, MI, USA). Fourteen days
later, the mice were lightly anesthetized with an intra-
peritoneal (i.p.) injection of 60 μg/kg body weight of
sodium pentobarbital (Nembutal, Abbott Laboratories,
North Chicago, IL, USA). The animals received intra-
tracheal (i.t.) instillation with 50 μl of Der p (2 mg/ml)
for the allergen challenge (AC), after which they were
held in an upright position for 1 min, so that they could
resume normal breathing. Figure 2A schematically de-
picts the complete protocol for XQLT treatment. The
XQLT dose that was used in this study was based on the
authors’ previous study [3] and the pilot study before
this research. In Group D, the mouse model for an
acute, Der p allergen-induced asthmatic attack was as
follows: initial sensitization with Der p on Day 0, a Der
p booster on Day 7, and an i.t. Der p AC on Day 14. The
animals were sacrificed on Day 16. To evaluate the effects
Figure 1 XQLT inhibited NGF, BDNF, TARC and p75NTR expression in LA4 cells stimulated with Der p. Pre-treatment (XP) and
co-treatment (XD) with XQLT in Der p-stimulated cells and merely XQLT treated cells (XC) were used to assess the effects of XQLT on
neurotrophin and associated receptor. (A) The supernatant was collected and analyzed by ELISA to obtain NGF, BDNF and TARC levels.
Student’s t test was performed versus Group D. Schematic of cell experiment groups is also shown under those ELISA data. (B) Whole cell
extracts were used for western blotting with anti-p75NTR antibody or anti-NGF antibody (commercial antibody also recognizes pro-NGF). Protein
expression level was assessed as western band density detected by densitometry and was depicted as proportional bar plots (negative group
level set as 1). Student’s t test was performed versus Group D. All the experiments in (A) and (B) were repeated for at least three times. The
values shown are means ± SD. * means p < 0.05, ** means p < 0.01, *** means p < 0.005 in (A) and (B).
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(Group T) were given 1 g/kg BW of XQLT once at 24 h
after AC, and mice in the preventive protocol (Group P)
were given 1 g/kg BW of XQLT six times, every other day
from Day 2 onward, with the last treatment administered
48 h before AC. Mice in Group XC (control) were adminis-
tered 1 g/kg BW of XQLT every other day from Day 2 on-
ward without Der p sensitization or AC. Group N (naive
group) comprised animals without Der p sensitization,
challenge or XQLT treatment. They were included in theexperiments for comparison. Each group, associated with
one experimental condition, comprised six mice.
Lyophilized house dust mites (Dermatophagoides
pteronyssinus; Der p) were purchased from Allergon
(Engelholm, Sweden). Crude Der p preparation was
extracted with ether. After dialysis with deionized water,
the Der p extract was lyophilized and stored at -70°C
until use. LPS concentration of the Der p preparations
was 1.96EU/mg of Der p (Limulus amebocyte lysate test;
E-Toxate; Sigma-Aldrich).
Figure 2 Respiratory flow resistance results showed inhibition of AHR by XQLT in a mouse model of Der p-induced acute asthma. (A)
Schematic of mice experiment groups. (B) Respiratory flow resistance was measured by intubation 2 d after Der p challenge. The standard curve
chart displays resistance values under methacholine challenge ranging from 0 mg/ml to 4 mg/ml. Values represent the means ±SD (n = 6 mice
for each group, all experiments repeated for at least three times). Student's t test was performed versus Group D (* means p < 0.01; ** means
p < 0.005). Student’s t test was also performed between Group P and Group T (# means p < 0.05).
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The lung function of mice that had been anesthetized with
sodium pentobarbital (60 μg/kg BW) was invasively ana-
lyzed. An 18-gauge stainless-steel cannula was inserted
into the trachea of each mouse, which was placed on
the FlexiVent system (ScireqW, Montreal, QC, Canada)
for forced oscillation measurements after tracheostomy
and consecutive examinations of total lung capacity
(TLC). According to manufacturer’s instruction and
previous studies [25,26], a single-compartment model
of respiratory mechanics was used to evaluate lung
function and the responses of the airway to metha-
choline (0 mg/ml to 4 mg/ml) 48 h after the Der p chal-
lenge. Total respiratory system resistance (Rrs) was
measured using a snapshot perturbation maneuver.
Methacholine was aerosolized for ventilation with an
ultrasonic nebulizer for 10 s, and 12 snapshot perturba-
tions were performed.Collection of serum and broncho-alveolar lavage
fluid (BALF)
The following procedures were based on previous study
[3,24] with slightly modification. The mice were sacri-
ficed by administering a sodium pentobarbital overdose
(20 mg/ml) following Der p challenge. After sacrifice, BALF
was collected by flushing the lung with two separate normal
saline through the trachea, around 1 ml of BALF was re-
covered. Cells were recovered from BALF by centrifugation
at 200 × g for 5 min at 4°C, then washed in red blood cell
lysis solution, and finally diluted with RPMI-1640 medium
(GIBCO/BRL, Life Technologies, Inc., Gaithersburg, MD,
USA). The total leukocyte content of the BALF was deter-
mined using a cytometer to be 1 × 105 cells/ml. Blood was
collected either through the axillary artery or directly from
the heart. The collected blood was left to stand for 1 h at
room temperature to clot. Centrifugation at 14,000 rpm
removed the clotted matter to obtain the serum.
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the BALF and serum
IgE, IgG1, and IgG2a concentrations in the BALF and
serum were measured using an ELISA kit (Bethyl
Laboratories, Inc). The wells of a 96-well ELISA plate
(Model No. 445101, NUNC) were coated with 100 μl of
affinity-purified mouse antibody in 50 mM carbonate-
bicarbonate buffer (pH 9.6). The plate was incubated at
room temperature (20°C–25°C) for 1 h. After the antibody
solution was removed, 200 μl of blocking solution that
contained 50 mM Tris, 0.14 M NaCl, and 1% bovine
serum albumin (BSA) (pH 8.0) was placed in each well
and incubated at room temperature for 30 min. The plates
were washed five times with PBST (0.05% Tween 20). The
dilutions of BALF or serum with sample/conjugate diluent
(50 mM Tris, 0.14 M NaCl, 1% BSA, 0.05% Tween 20)
were added to the wells. After being sealed with adhesive
tape, the plates were incubated at room temperature for
1 h and again washed five times. After 100 μl of diluted
horseradish peroxidase (HRP)-conjugated antibody was
added to each well, the plates were again incubated at
room temperature (20°C–25°C) for 1 h. Thereafter, the
plates were again washed five times, and 100 μl of tetra-
methylbenzidine (TMB) substrate solution was added to
each well. The plates were then kept in the dark at room
temperature for 15 min for fluorescence developing. The
enzyme reaction was stopped by adding 100 μl of stop so-
lution (0.18 M H2SO4). Absorbance was measured at a
wavelength of 450 nm on an ELISA plate reader.
Antibody ELISA: Mouse IgE ELISA Quantitation Set,
Bethyl Laboratories, Inc. E90-115; Mouse IgG1 ELISA
Quantitation Set, Bethyl Laboratories, Inc. E90-105;
Mouse IgG2 ELISA Quantitation Set, Bethyl Laboratories,
Inc. E90-107;IFN-γ/ IL-5/IL-13/TGF-β1/TARC/NGF/BDNF concentrations
in BALF, serum, and cell line supernatants
The concentrations of NGF and BDNF in the BALF,
serum, and cell culture supernatant were measured
using the appropriate ELISA kits (NGF & BDNF Emax
Immuno-Assay Systems), according to the manufac-
turers’ instructions (Promega, Madison, WI, USA). The
concentrations of IFN-γ, IL-5, TGF-β1, TARC and IL-13
in the BALF, serum, and cell culture supernatants were
measured using an ELISA kit according to the manufac-
turer’s instructions.
Cytokine ELISA: NGF EmaxW ImmunoAssay System,
Promega G7630; BDNF EmaxW ImmunoAssay System,
Promega G7610; mouse IFN-gamma {R&D Systems, Inc.
DuoSet ELISA DY485}; mouse IL-5 {R&D Systems, Inc.
DuoSet ELISA DY405}; mouse TGF-beta1 {R&D Sys-
tems, Inc. DuoSet ELISA DY1679}; mouse IL-13 {R&D
Systems, Inc. DuoSet ELISA DY413}.Lymphocyte/macrophage/neutrophil/eosinophil
percentages in the BALF
BALF cells were spun down onto a glass slide at 360 rpm
for 8 min by cytospinning. The slides were then dried
and stained by the hematoxylin and eosin (H&E) or
eosinophil-specific staining methods (Eosinophil-Mast
Cell Stain Kit, CEM-1-IFU; ScyTek Laboratories, Inc.,
Utah, USA). More than 200 cells were counted under
a photomicroscope and the percentages of lymphocytes,
macrophages, neutrophils, and eosinophils were thereby
determined.
Immunohistochemistry
The entire lung was removed and embedded in paraffin
for slicing. The paraffin lung slices were mounted on
glass slides. The paraffin was then depleted at 60°C. Each
slice was then sequentially treated with the following re-
agents; xylene, ethanol, 3% H2O2 (80% methanol) (v/v),
and 0.01 M sodium citrate buffer (pH 6.0, 95°C). After
10% non-fat milk was used to block the cooled slice, a
rabbit polyclonal anti-p75NTR antibody or a rabbit poly-
clonal anti-TrkA antibody (Abcam, Cambridge, UK) were
used for immunostaining (4°C, overnight). Anti-Rabbit
IgG antibody (FITC or Phycoerythrin conjugated; Abcam,
Cambridge, UK) was used as a secondary antibody to de-
velop fluorescence. The developed slice was observed
under a light microscope. The area density of fluorescence
was analyzed using an image analysis system. The fluores-
cence density results are shown as a bar graph. Single
Antibody: anti-p75NTR {Abcam Inc. ab8874}; anti-TrkA
antibodies {Abcam Inc. ab76291}.
Statistical analysis
The data are presented as mean ± standard deviation.
Statistical comparisons were performed using Student’s t
test analysis, with significance set at P < 0.05 or as indi-
cated in each figure legend (two-sided test). All the stat-
istical differences are indicated in the figure legends.
Results
XQLT inhibited NGF, BDNF, and p75NTR expression in
LA4 cell line following Der p stimulation
An in vitro model of mouse lung adenoma cells (LA4
cell line) was used to study the possible mechanism of
XQLT. Schematic of cell experimental groups is shown in
Figure 1A. LA4 cells stimulated with Der p produced three
times more NGF than un-stimulated cells did (“D” and “N”
in Figure 1A). Cells with XQLT treatment alone (XC)
exhibited decreased NGF expression compared to un-
treated cell (N). Treatment with XQLT alone inhibited the
expression of NGF in LA4 cells without causing toxicity
(by MTTassay, data not shown). Pre-treatment with XQLT
(“XP” in Figure 1A) decreased NGF expression more than
did co-treatment with XQLT (“XD” in Figure 1A). A single
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not shown) of XQLT as a pre-treatment appeared to suf-
fice for the inhibition Der p-induced NGF expression
(“XP” in Figure 1A). LA4 cells exhibited high baseline
levels of BDNF production. Der p stimulation slightly ele-
vated LA4 BDNF levels, whereas XQLT clearly reduced
them (“XP” and “XD” in Figure 1A). The levels of thymus-
and activation-regulated cytokine (TARC), which is the
cytokine that recruits eosinophil and Th2 inflammatory
cells in the early phase of an allergic reaction, were also re-
duced in XQLT-treated LA4 cells (“XP” and “XD” in
Figure 1A).
p75NTR knockout mice are known to have a lower
response to allergic stimulation [20]. XQLT also inhibited
the expression of p75NTR at the protein level in LA4
(“XP”, “XD” and “XC” in Figure 1B). Pre- and co-treatment
(XP and XD) with XQLT indistinguishably reduce p75NTR
levels. XQLT treatment (Figure 1B) also inhibited the
expression of long-form pro-NGF, which was induced
by Der p. A decrease in pro-NGF level might be respon-
sible for the observed decrease in NGF level in the cell
culture supernatant.
XQLT had a regulatory effect on neurotrophin and
TARC from epithelial cells that were stimulated by Der p.
An established acute asthmatic mouse model was then
used to study how XQLT would affect neurotrophin in the
asthma reaction.
Measurements of respiratory flow resistance showed
inhibition of AHR by XQLT in Der p-induced acute asthma
Figure 2A schematically depicts the experimental groups
of mice. Figure 2B reveals that the Der p-challenged mice
that had been preventively administered XQLT orally
(Group P) had a significantly lower respiratory resistance
than did the Der p-challenged mice that had not been
treated with XQLT (Group D; p < 0.01 marked by * symbol).
The preventive strategy also decreased the respiratory
flow resistance significantly more than did the therapeutic
strategy (Group T; p < 0.05 marked by # symbol). Mice
treated with XQLT oral administration only (Group XC)
had airway resistance similar to the airway resistance of
naive mice (Group N). These results suggested that XQLT
positively inhibited Der p-induced AHR in mice. The air-
way resistance of Group XC was not increased. Although
XQLT has been found to inhibit AHR in Der p stimulated
mice, the supported data was based on the indirect Penh
method [3]. In this research, AHR values were mea-
sured directly via intubation in a mouse model of Der
p-challenged acute asthma and could be more precise.
BALF cytokine profile and eosinophil infiltration in the
lung of the acute asthma mouse model
Both IL-5 and IL-13 are known to be involved in the
recruitment of eosinophil. However, the data did notshow that XQLT had any clear effect on IL-5 or IL-13
(Figure 3A). XQLT did not have any significant effects
on IFN-γ levels in this Der p-induced acute asthma mice
model (Figure 3A). However, the thymus-and activation-
regulated cytokine (TARC), which is known to be involved
in the Th2-cell attraction response and may be regulated
by NGF [27], was greatly suppressed by both strategies of
XQLT administration (Group P and Group T). If these re-
lationships between NGF, BDNF and TARC were taken
together, XQLT might regulate neurotrophin and TARC
for showing preventive effect on asthmatic processes.
To understand the possible pathways affected by XQLT,
further research was conducted to find the target receptor
of XQLT effect.
The data obtained using specific eosinophil/mast cell
staining kits revealed that Der p stimulation induced the
infiltration of eosinophil (light pink cells; as arrow pointed
in Figure 3B) into the lungs. Both preventive (Group P)
and therapeutic strategies (Group T) reduced eosinophil
infiltration (bottom-left bar graph in Figure 3B).
Effects of XQLT on total and Der p-specific IgE, IgG1, and
IgG2a levels in serum and BALF in Der p-induced acute
asthma mice model
Monitoring immune-pharmacological and physiological ef-
fects is important when a decotion is used for study in an
asthma animal model. Our analysis of Der p-induced anti-
bodies revealed that XQLT (Group P and Group T) tended
to decrease serum total IgE, IgG1, and IgG2a levels,
particularly in mice that had been subject to preventive
strategy (Figure 4A). Der p-specific IgE levels were not sig-
nificantly altered by XQLT, but Der p-specific IgG1 and
IgG2a levels were decreased by XQLT, especially in the
preventive strategy group (Group P in Figure 4A). XQLT
also reduced total cell infiltration in BALF (Group P and
Group T in Figure 4B). Mice treated with XQLT alone
(Group XC) had antibody quantities or cell infiltration
similar to those in naïve mice (Group N). The results sug-
gested that repeated XQLT treatments could decrease al-
lergic inflammation in a mouse model of Der p-challenged
acute asthma.
XQLT inhibited NGF and BDNF levels in Der p-induced
acute asthma
Der p stimulation evidently increased NGF levels in the
serum and BALF (Figure 5A). The preventive strategy
(Group P) clearly reduced NGF levels in BALF, whereas
the effect of the therapeutic strategy (Group T) was uncer-
tain (Figure 5A). Those results showed similar trends in
compared with the trends of AHR measurements shown
in Figure 2B. Our results suggested that XQLT might
down-regulate the AHR response of asthma by regulating
NGF, a factor in the early phase of asthma [28,29]. Serum
NGF was not significantly affected in either the therapeutic
Figure 3 BALF cytokine profile and eosinophil infiltration in the lung of a mouse model of acute asthma. (A) BALF was collected for
ELISA analysis to evaluate IL-5, IL-13, IFN-γ, TARC, and TGF-β1 levels. TARC levels were clearly decreased by XQLT (Group P and T). Values shown
are the mean ± SD (Student’s t test versus Group D) of the six mice in each group. All experiments were repeated for at least three times.
* means p < 0.05; *** means p < 0.01 (B) Eosinophil infiltration in the lungs of mice in acute asthma model. Lung sections were prepared for a
special stain to identify eosinophil (light pink; as arrow pointed) and structure cells (deep blue). Eosinophil counts were calculated from 30 vision
fields and listed at the bottom-left of the images in the bar plot. Values shown are the mean ± SD (Student’s t test versus Group D; * means
p < 0.05; *** means p < 0.01) (n = 6 mice for each group). All experiments were repeated for at least three times.
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which XQLT down-regulated NGF levels in the BALF
without affecting serum NGF levels will be investigated
further. The therapeutic strategy appeared not to cause
significant differences of BALF NGF.
In contrast, both the preventive and therapeutic strat-
egies reduced BDNF levels in the serum more than in the
BALF (Figure 5B). BDNF has been found to play a role in
the late phase of asthma [14], and has been reported to be
involved in the infiltration of eosinophils, which are known
for their persistent activity in asthma, into the lungs [11].XQLT reduces Der p-induced p75NTR and TrkA
expression in lungs
p75NTR knockout mice are known to have a lower
response to allergic stimulation [20]. Immunofluores-
cence was shown as Total Area density in bar graph
of Figure 6. Der p stimulation induced high level of
p75NTR expression in the lung (Group D). Data herein
revealed that XQLT reduced Der p-stimulated p75NTR in
the lungs of acute asthmatic mice model. XQLT might
affect the asthmatic reaction by regulating p75NTR ex-
pression (Figure 6A). The preventive and therapeutic oral
Figure 4 Effects of XQLT on serum total and Der p-specific IgE, IgG1, and IgG2a levels in a mouse model of Der p-induced acute
asthma. (A) XQLT administration, especially as a preventive strategy, decreased serum total IgE, IgG1, and IgG2a levels. Der p-specific IgG1 and
IgG2a levels were also decreased by the preventive XQLT strategy. * means p < 0.05; *** means p < 0.01 (B) Total cell infiltration in the lungs was
also decreased by the action of XQLT. Values represent the means ± SD (n = 6 mice for each group, all experiments repeated for at least three
times; * means p < 0.05; ** means P < 0.01; *** means p < 0.005). Student’s t test was performed versus Group D in (A) and (B).
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ference on p75NTR, revealing that other inhibition mecha-
nisms must exist (Group P and Group T in Figure 6A).
The inhibition of p75NTR and BALF NGF by XQLT
might together explain how XQLT prevents the Der
p-induced asthmatic reaction. TrkA is also involved in
NGF-related allergic reaction. Our data also showed that
Der p-stimulated mice to which XQLT was orally adminis-
tered expressed less TrkA in the lungs (Group P and
Group T in Figure 6B) than did the Der p-stimulated mice
(Group D).
Discussion
XQLT has been reported to inhibit allergic reactions in
mice models of both acute and chronic Der p-inducedasthma [3,24]. In this study, the action of XQLT was
found to inhibit allergic reactions which were correlated
with the allergic asthma response. IgE levels (Figure 4A)
and the extents of eosinophil and leukocyte infiltration
(Figure 3B and Figure 4B) were reduced, causing the
XQLT-induced down-regulation of any prolonged aller-
gic reaction in the Der p-induced acute asthma model.
Hence, in this mouse model, XQLT might affect the Th2
response, which is actively involved in allergic reactions.
Yet IgG2a which is considered to be Th1 reaction prod-
uct will be controversial because XQLT also decreased
IgG2a. Der p induced more IgG1 than IgG2a that indeed
indicated a Th2 favored reaction. It seemed that XQLT
might also have an effect on Th1 reaction. By further
analyzing cytokine such as IL-12 or IL-4 may reveal the
Figure 5 XQLT decreased NGF and BDNF levels in a mouse model of acute asthma. (A) NGF and (B) BDNF levels in the serum and BALF
were measured after sacrificing the mice. Values shown are the mean ± SD (Student’s t test versus Group D) of the six mice in each group. The
preventive XQLT strategy (P) decreased NGF and BDNF levels the most, particularly in the BALF and serum. * means p < 0.05; ** means P < 0.01;
*** means p < 0.005.
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TGF-β1 which is known to induce Treg cell that inhibits
T helper cell reaction including both Th1 and Th2 [30].
XQLT did not inhibit TGF-β1 (Figure 3A) in this re-
search. Former research also indicated that XQLT in-
duced CD4-CD8+ T cell or CD4-CD8- T cell [3] that
usually represents phenotype of Treg cell. By analyzing
IL-10 expression [31] and subset of infiltrated cell with
different phenotype in BALF in the future will show how
XQLT affect these factors thus regulating T helper
reaction.
Yamada et al. [4] reported that XQLT treatment was
effective in their mouse model of ovalbumin-induced
acute asthma. After an ovalbumin challenge and the
XQLT oral administration, elevated NGF level in the
BALF has been observed [4]. Since NGF and other
neurotrophin have been reported to be factors that are
involved in asthmatic reactions, XQLT may influence al-
lergic reactions in asthma by regulating neurotrophin.
In this study, a mouse model of Der p challenge-
induced acute asthma was used to show that XQLT
inhibited the release of NGF (Figure 5A) and p75NTR re-
ceptor expression (Figure 6A) in the lungs. The preventive
XQLT strategy inhibited NGF expression more than the
therapeutic XQLT strategy (Figure 5A). Therefore, XQLTdown-regulated Th2 responses and inhibited allergic reac-
tions. AHR, which can clearly indicate acute asthma at-
tacks and is directly affected by NGF, was also reduced by
XQLT (Figure 2B). The preventive XQLT strategy also
inhibited the expression of p75NTR receptor more than
did the therapeutic XQLT strategy. Although serial doses
of XQLT were in the preventive strategy (Figure 5A), a
single dose of XQLT in vitro, administered as a pre-
treatment, was sufficient to inhibit Der p-induced NGF
production (Figure 1A; XP). Pre-treatment of LA4 with
XQLT (Figure 1A; XP) reduced both NGF and TARC
levels, which finding was consistent with the in vivo data.
Western blot assays revealed that pre-treating LA4 cells
with XQLT inhibited p75NTR receptor and pro-NGF ex-
pression in vitro (Figure 1B). Hence, XQLT was predicted
to have a preventive effect on the acute asthma.
Both in vivo and in vitro data revealed that XQLT
clearly reduced BDNF levels. Pre-treatment with a single
dose of XQLT in vitro reduced BDNF levels (Figure 1A;
XP) more than did preventive XQLT administration
in vivo (Figure 5B; Group P). BDNF has been reported
to be a constitutive factor in the lungs and plays an im-
portant role in lung development [32]. The effects of
BDNF are most apparent in the late phase of asthma, ra-
ther than in the acute phase [14], and BDNF has also
Figure 6 XQLT decreased Der p-induced p75NTR and TrkA expression in the lungs. The Der p-challenged lung was used to be sliced for
immunofluorescence staining with an anti-p75NTR antibody or an anti-TrkA antibody. (A) p75NTR (B) TrkA. The symbol {I} represented antibody
isotype control. Fluorescence was measured by image analysis system and shown as total area density in the bar plot. Fluorescence area density
was average fluorescence density values from 36-50 vision fields. Values shown are the mean ± SD (Student’s t test versus Group D) (n = 6 mice
for each group). All experiments were repeated for at least three times. * mean p < 0.05; ** means p < 0.01.
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into the lungs [11]. BDNF also has an important role in
smooth muscle hypertrophy which contributes to per-
sistent late phase of asthma [15,33]. XQLT inhibited
TARC (Figures 1A and 3A), which has been shown to
be a factor that attracts eosinophil in early phase of
immunological reactions [34-36]. XQLT also reduced
BALF NGF (Figure 5A) which has been shown to be a
survival factor of eosinophil in local compartments such
as alveoli and bronchiole [11,13]. These results may elu-
cidate the effects of XQLT on eosinophil, and help to
explain how XQLT performs a prolonged regulatory func-
tion in latent asthma. XQLT targets both eosinophil and
neurotrophin in allergic asthma, and this targeting is likely
to support the preventive value of XQLT. By regulating
BALF NGF, TARC and serum BDNF levels, XQLT maycontrol allergic inflammation and eosinophil infiltration in
both the early and the late phases of asthma.
The exact mechanisms of action of the components of
XQLT decotion remain to be elucidated. By fractionation
of XQLT with chromatographic methods, such as those
involving silica gel columns, can further elucidate the
mechanisms of XQLT, including the pharmacodynamics
and interactions. This fractionation research of XQLT
will enable treatment with XQLT to be more precisely
monitored to increase the effectiveness of treatment of
asthma patients. Nagai et al. [4] reported that XQLT
treatment was effective in their ovalbumin-induced acute
asthmatic mouse model and might provide a hint for
studying the XQLT mechanism. In their research, one of
the XQLT ingredients, Pinellaiae ternata, played an im-
portant role in decreasing OVA-specific IgE. Lee et al.
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Pinellaiae ternata might play a definite role in decreasing
Th2 reaction in asthmatic animal models. Pinellaiae
ternata is in highest proportion of XQLT components. It
is worthy to know how Pinellaiae ternata will affect the
neurotrophin in an asthma mouse model.
Our data revealed that XQLT influenced members of
the neurotrophin family. According to internal medical
principles and acupuncture practices in TCM, XQLT can
be used to resolve symptoms or diseases that are associ-
ated with qi malfunctions of the bladder meridian, which
used to be thought to be related to functions of the auto-
nomic nervous system. By interfering with the neuro-
trophin, XQLT and its derivative decotions may act on the
nervous system and thereby potentially regulate spinal or
brain functions. Neurotrophin also appear to have a differ-
ent role in the immune system, such as autoimmunity.
One of our future goals is to extend the use of XQLT and
its derivative decotions in the treatment of neurotrophin-
related diseases of immune malfunction.
Conclusion
In conclusion, XQLT regulates neurotrophin in a Der p
stimulated cell line model and in an asthmatic mouse
model. The effects of XQLT on neurotrophin may cause
down-regulation of asthma reaction including AHR and
eosinophil infiltration.
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